These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
286 related items for PubMed ID: 8667431
1. Altered pharmacokinetics of vinblastine in Mdr1a P-glycoprotein-deficient Mice. van Asperen J, Schinkel AH, Beijnen JH, Nooijen WJ, Borst P, van Tellingen O. J Natl Cancer Inst; 1996 Jul 17; 88(14):994-9. PubMed ID: 8667431 [Abstract] [Full Text] [Related]
2. Comparative pharmacokinetics of vinblastine after a 96-hour continuous infusion in wild-type mice and mice lacking mdr1a P-glycoprotein. van Asperen J, van Tellingen O, Schinkel AH, Beijnen JH. J Pharmacol Exp Ther; 1999 Apr 17; 289(1):329-33. PubMed ID: 10087021 [Abstract] [Full Text] [Related]
3. Homozygous disruption of the mdrla P-glycoprotein gene affects blood-nerve barrier function in mice administered with neurotoxic drugs. Saito T, Zhang ZJ, Ohtsubo T, Noda I, Shibamori Y, Yamamoto T, Saito H. Acta Otolaryngol; 2001 Sep 17; 121(6):735-42. PubMed ID: 11678173 [Abstract] [Full Text] [Related]
6. Resolution of P-glycoprotein and non-P-glycoprotein effects on drug permeability using intestinal tissues from mdr1a (-/-) mice. Stephens RH, O'Neill CA, Bennett J, Humphrey M, Henry B, Rowland M, Warhurst G. Br J Pharmacol; 2002 Apr 17; 135(8):2038-46. PubMed ID: 11959808 [Abstract] [Full Text] [Related]
7. Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport. Barthomeuf C, Demeule M, Grassi J, Saidkhodjaev A, Beliveau R. Planta Med; 2006 Jun 17; 72(7):634-9. PubMed ID: 16739070 [Abstract] [Full Text] [Related]
8. Tissue disposition, excretion and metabolism of vinblastine in mice as determined by high-performance liquid chromatography. van Tellingen O, Beijnen JH, Nooijen WJ, Bult A. Cancer Chemother Pharmacol; 1993 Jun 17; 32(4):286-92. PubMed ID: 8324870 [Abstract] [Full Text] [Related]
12. What kinds of substrates show P-glycoprotein-dependent intestinal absorption? Comparison of verapamil with vinblastine. Ogihara T, Kamiya M, Ozawa M, Fujita T, Yamamoto A, Yamashita S, Ohnishi S, Isomura Y. Drug Metab Pharmacokinet; 2006 Jun 17; 21(3):238-44. PubMed ID: 16858128 [Abstract] [Full Text] [Related]
14. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin. Barthomeuf C, Grassi J, Demeule M, Fournier C, Boivin D, Béliveau R. Cancer Chemother Pharmacol; 2005 Aug 17; 56(2):173-81. PubMed ID: 15824923 [Abstract] [Full Text] [Related]
15. P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans. Schuetz EG, Schinkel AH, Relling MV, Schuetz JD. Proc Natl Acad Sci U S A; 1996 Apr 30; 93(9):4001-5. PubMed ID: 8633005 [Abstract] [Full Text] [Related]